Correlation Between 4D Molecular and Aerovate Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Aerovate Therapeutics, you can compare the effects of market volatilities on 4D Molecular and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Aerovate Therapeutics.

Diversification Opportunities for 4D Molecular and Aerovate Therapeutics

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between FDMT and Aerovate is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of 4D Molecular i.e., 4D Molecular and Aerovate Therapeutics go up and down completely randomly.

Pair Corralation between 4D Molecular and Aerovate Therapeutics

Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to under-perform the Aerovate Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, 4D Molecular Therapeutics is 1.22 times less risky than Aerovate Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Aerovate Therapeutics is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  220.00  in Aerovate Therapeutics on August 24, 2024 and sell it today you would earn a total of  41.00  from holding Aerovate Therapeutics or generate 18.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

4D Molecular Therapeutics  vs.  Aerovate Therapeutics

 Performance 
       Timeline  
4D Molecular Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 4D Molecular Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Aerovate Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

4D Molecular and Aerovate Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 4D Molecular and Aerovate Therapeutics

The main advantage of trading using opposite 4D Molecular and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.
The idea behind 4D Molecular Therapeutics and Aerovate Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity